Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01590238 · ClinicalTrials.gov registry record · Phase 3
Enhancing Hair Density With Platelet Rich Fibrin Matrix (PRFM)
A Phase 3 study, sponsored by The New York Eye & Ear Infirmary.
- Completed
- Registry status
- Phase 3
- Development phase
- 15
- Enrollment target
NCT01590238 is a Phase 3 study that has completed, run by The New York Eye & Ear Infirmary. The registered enrollment target is 15 participants.
The verdict
NCT01590238, a Phase 3 study, has completed, sponsored by The New York Eye & Ear Infirmary.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 15 participants
- Enrollment target
Study Summary
Clinical alopecia occurs due to miniaturization of the hair shafts as well as loss of active production of hair shafts. PRFM has been shown to induce dermal angiogenesis, and anecdotal findings of improvement of hair appearance after PRFM injection in the scalp suggest that PRFM may play a role in the treatment of thinning hair. Patients will be treated on a monthly basis with intradermal injections of autologous PRFM for 3 months. Changes in hair density will be assessed by comparing pre- and post-treatment photographs and non-invasive measurements of hair density at 1, 2, 3, 4 and 6 months after initial treatment.
Interventions
- BIOLOGICAL PRFM treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2012-05 |
| Est. Completion | 2013-11 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01590238
The ClinicalTrials.gov registry entry for NCT01590238 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The New York Eye & Ear Infirmary, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PRFM treatment is the first listed.
NCT01590238 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01590238 about?
NCT01590238 is a clinical study titled "Enhancing Hair Density With Platelet Rich Fibrin Matrix (PRFM)". Clinical alopecia occurs due to miniaturization of the hair shafts as well as loss of active production of hair shafts. PRFM has been shown to induce dermal angiogenesis, and anecdotal findings of improvement of hair appearance after PRFM injection in the scalp suggest that PRFM may play a role in t...
What is the current status of trial NCT01590238?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 15 participants. The study started on 2012-05. Estimated completion is 2013-11.
What interventions are being tested in trial NCT01590238?
The interventions under investigation include: PRFM treatment (BIOLOGICAL).
Who is sponsoring clinical trial NCT01590238?
This trial is sponsored by The New York Eye & Ear Infirmary, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.